JOIN US
E-PAPER
Home
Elections
India
Karnataka
Opinion
World
Business
Sports
Entertainment
Video
IPL
News Shots
Explainers
Bengaluru
Science
Trending
Brandspot
Photos
Newsletters
Home
News Shots
Trending
Menu
×
ADVERTISEMENT
ADVERTISEMENT
Biocon
Biocon to sell branded formulations business to Eris Lifesciences for Rs 1,242 crore
The deal, which is expected to close by April 15, 2024, includes the acquisition of insulin brands Basalog and Insugen which Eris said will help its diabetes treatment franchise reach 10 billion rupees in revenue, without specifying a timeline.
14 March 2024, 11:30 IST
Biocon to sell branded formulations business to Eris Lifesciences for Rs 1,242 crore
14 March 2024, 11:30 IST
Biocon gets over Rs 3 crore penalty over GST related issues
The company has received an order of adjudication imposing a penalty of Rs 3,03,78,465 dated February 22, 2024, from the office of Deputy Commissioner of Commercial Taxes, Divisional GST Office, Bengaluru.
23 February 2024, 11:39 IST
Biocon gets over Rs 3 crore penalty over GST related issues
23 February 2024, 11:39 IST
Biocon net profit more than doubles to Rs 126 cr in Q2FY24
The Bengaluru-headquartered company’s revenue grew 52% year-on-year to Rs 3,620 crore, led largely by a revenue rise of 97% in its biosimilars business segment.
11 November 2023, 00:41 IST
Biocon net profit more than doubles to Rs 126 cr in Q2FY24
11 November 2023, 00:41 IST
Official action indicated for Biocon arm's unit in Malaysia after USFDA inspection
The OAI (official action indicated) status may cause delay and/or withholding of pending product approvals or supplements from the facility, Biocon Ltd said in a regulatory filing.
18 October 2023, 10:45 IST
Official action indicated for Biocon arm's unit in Malaysia after USFDA inspection
18 October 2023, 10:45 IST
SII to double investment in Biocon's unit to $300 mn
Serum Institute of Life Sciences had already invested $150 million in Biocon Biologics in November 2022
26 April 2023, 01:10 IST
SII to double investment in Biocon's unit to $300 mn
26 April 2023, 01:10 IST
Biocon Biologics elevates Shreehas Tambe as MD and CEO
Tambe started out as a management trainee in 1997
06 December 2022, 00:53 IST
Biocon Biologics elevates Shreehas Tambe as MD and CEO
06 December 2022, 00:53 IST
John Shaw, husband of Kiran Mazumdar Shaw, passes away
Shaw, who was born in 1949, was a member of the board of directors since 1999 and served as a foreign promoter
24 October 2022, 13:15 IST
John Shaw, husband of Kiran Mazumdar Shaw, passes away
24 October 2022, 13:15 IST
Biocon, Yoshindo tie up to sell biosimilars in Japan
Denosumab, a biosimilar referencing Prolia, is used to treat osteoporosis, which causes bones to become weak and brittle
17 October 2022, 21:56 IST
Biocon, Yoshindo tie up to sell biosimilars in Japan
17 October 2022, 21:56 IST
CBI files charge sheet in Biocon case against 5 persons
Biocon Biologics, a subsidiary of Kiran Mazumdar Shaw-led Biocon, however, had denied the allegations of bribery
25 August 2022, 16:05 IST
CBI files charge sheet in Biocon case against 5 persons
25 August 2022, 16:05 IST
Roshni Nadar remains richest Indian woman: Report
Nadar saw her net worth jump 54 per cent in 2021 to Rs 84,330 crore
27 July 2022, 11:31 IST
Roshni Nadar remains richest Indian woman: Report
27 July 2022, 11:31 IST
<
1
2
...
9
>